Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
Sponsor: Showa Inan General Hospital
Summary
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Official title: A Prospective Study on the Efficacy and Safety of a Novel Oral Drug, Etrasimod, in Elderly Patients With Ulcerative Colitis
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-10-01
Completion Date
2026-09-30
Last Updated
2025-12-11
Healthy Volunteers
No
Conditions
Interventions
Etrasimod administration
2 mg of Etrasimod is orally administered everyday.
Locations (1)
Showa Inan General Hospital
Komagane, Nagano, Japan